Search results for "belagenpumatucel-L"

showing 1 items of 1 documents

Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer?

2014

Abstract: Immunotherapy has been studied for many years in lung cancer without significant results, making the majority of oncologists quite skeptical about its possible application for non-small cell lung cancer treatment. However, the recent knowledge about immune escape and subsequent cancer immunoediting has yielded the development of new strategies of cancer immunotherapy, heralding a new era of lung cancer treatment. Cancer vaccines, including both whole-cell and peptide vaccines have been tested both in early and advanced stages of non-small cell lung cancer. New immunomodulatory agents, including anti-CTLA4, anti-PD1/PDL1 monoclonal antibodies, have been investigated as monotherapy …

OncologyPD-L1medicine.medical_specialtyLung NeoplasmsSettore MED/06 - Oncologia Medicamedicine.medical_treatmentRacotumomabIpilimumabCIMAvaxtecemotideCancer VaccinesracotumomabCancer immunotherapyCarcinoma Non-Small-Cell LungInternal medicinePD-1medicineHumansbelagenpumatucel-LPharmacology (medical)ipilimumabLung cancerGVAXnon-small cell lung cancerNeoplasm StagingClinical Trials as TopicMAGE-A3CIMAvax; GVAX; MAGE-A3; PD-1; PD-L1; TG4010; belagenpumatucel-L; immunotherapy; ipilimumab; non-small cell lung cancer; racotumomab; tecemotide; vaccinesbusiness.industryAntibodies MonoclonalCancerImmunotherapyvaccinesmedicine.diseaseGVAXOncologyImmunologyTecemotideTG4010Human medicineimmunotherapybusinessmedicine.drug
researchProduct